UK Study Vital in Leptospirosis Vaccine Development
- Topics: Article, Horse Industry News, Leptospirosis, Vaccinations

Researchers at the University of Kentucky Veterinary Diagnostic Lab (VDL), in Lexington, recently celebrated the culmination of many years of work with the release of a vaccine for equine leptospirosis.
In building a case for the vaccine, a process that took 10 years, VDL director Craig Carter, DVM, PhD, Dipl. ACVPM, and his colleagues approached Zoetis, a global animal health company, with their research. They recruited 29 state laboratories in the United States and one in Ontario, Canada, to gather blood from 1,495 horses.
“What we found confirmed our suspicions,” Carter said. “Horses are exposed to leptospirosis across the country. It’s one of those bugs that are everywhere. It’s a unique, coiled bacteria that persists in moist environments
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with